ad info

CNNin
 MAIN PAGE
 WORLD
 ASIANOW
 U.S.
 LOCAL
 POLITICS
 WEATHER
 BUSINESS
 SPORTS
 TECHNOLOGY
 NATURE
 ENTERTAINMENT
 BOOKS
 TRAVEL
 FOOD
 HEALTH
 AIDS
 Alternative
 Cancer
 Diet & Fitness
 Heart
 Men
 Seniors
 Women
 STYLE
 IN-DEPTH

 Headline News brief
 daily almanac
 CNN networks
 CNN programs
 on-air transcripts
 news quiz

  CNN WEB SITES:
CNN Websites
 TIME INC. SITES:
 MORE SERVICES:
 video on demand
 video archive
 audio on demand
 news email services
 free email accounts
 desktop headlines
 pointcast
 pagenet

 DISCUSSION:
 message boards
 chat
 feedback

 SITE GUIDES:
 help
 contents
 search

 FASTER ACCESS:
 europe
 japan

 WEB SERVICES:
Health

Heart researchers replace blocked vessels by growing new ones

surgery
Angiogenesis may provide an alternative to standard treatment for heart patients  

Valve repair also encouraging, doctors say

November 9, 1998
Web posted at: 9:35 p.m. EST (0235 GMT)
In this story:

DALLAS (CNN) -- Doctors and researchers meeting at the American Heart Association's annual conference are considering an experimental treatment called angiogenesis, in which scientists use either medication or gene therapy to grow new blood vessels in the heart.

As with most experimental treatments, researchers caution that it's still too early for heart patients to get excited about the process.

But some patients already have experienced positive results.

Take real estate developer Gil Gilman.

"I could not walk across the street without suffering heart pains or angina," Gilman said. Standard drug treatments, bypass surgery and angioplasty were not successful in ending his pain.

Then doctors at Emory University in Atlanta offered Gilman angiogenesis. Since the treatment, Gilman said, he's gotten stronger, and can "go back to doing basically anything I wanted to do."

Emory researchers have done safety tests of their angiogenesis procedure on 58 patients and say they are pleased with the results.

But scientists say the treatment is still in the early stages of development. One concern is that new blood vessels could grow in places where they are not wanted, like the eyes and kidneys.

Encouraging results from Tufts study

A team at Tufts University in Boston used gene therapy on 16 male patients with severe blockages. Researchers told the AHA meeting Monday the men had less chest pain after the treatment and had to take fewer drugs.

graphic
Angiogenesis causes new blood vessels to grow in the heart using drugs or gene therapy  

The treatment involved injecting a gene that controls production of VEGF, or vascular endothelial growth factor, which instructs the body to grow new blood vessels.

The 16 volunteers, aged 53 to 71, all had suffered heart attacks. All had blocked arteries, and all had had either bypass surgery or angioplasty to stretch open their clogged blood vessels -- many of them several times.

Yet each time the blockages came back. Most of the men had such bad chest pain they could not live normal lives.

After having the VEGF injected into their hearts, all but one of the patients reported the reduction in chest pain was "marked," starting just 10 days after treatment.

Again, researchers stressed that more research is needed, but they said the potential for treatment is huge.

Dr. Jeffrey Isner said about 250,000 patients a year have ischemia, or blocked blood flow, for which bypass surgery, angioplasty or drugs have not worked.

"For these patients there is currently no other treatment option," he told a news conference.

Surgeon says valve repair can extend lives

Also at the AHA meeting Monday, University of Michigan surgeon Steven Bolling said surgical repair of a heart valve can greatly extend survival rates for patients with congestive heart failure, which claims about 250,000 lives each year in the United States.

Bolling developed the new procedure as an alternative for patients whose only other hope was a heart transplant.

It involves reconstruction of the mitral valve, which controls blood flow between the upper and lower chambers of the left ventricle, the heart's main pumping chamber.

Bolling has performed the operation 92 times in the past five years. He said one-year and two-year survival rates have been 80 percent and 70 percent, respectively. He said those rates would have been, at best, 20 percent without the surgery.

About 100 of the operations have been performed at other U.S. hospitals, said Bolling, who added he hoped they would become a standard treatment.

"I hope we can intervene and avert the inexorable march toward heart failure and death," he said.

Correspondent Rhonda Rowland and Reuters contributed to this report.

Related stories:
Latest Headlines

Today on CNN

Related sites:

Note: Pages will open in a new browser window

External sites are not
endorsed by CNN Interactive.

SEARCH CNN.com
Enter keyword(s)   go    help

  
 

Back to the top
© 2000 Cable News Network. All Rights Reserved.
Terms under which this service is provided to you.
Read our privacy guidelines.